Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Glioma | 77 | 2024 | 3498 | 7.460 |
Why?
|
Isocitrate Dehydrogenase | 60 | 2024 | 950 | 7.320 |
Why?
|
Brain Neoplasms | 121 | 2024 | 9101 | 6.690 |
Why?
|
Glioblastoma | 39 | 2024 | 3458 | 2.980 |
Why?
|
Oligodendroglioma | 9 | 2024 | 274 | 2.330 |
Why?
|
Mutation | 91 | 2024 | 30213 | 2.180 |
Why?
|
Astrocytoma | 15 | 2024 | 773 | 2.120 |
Why?
|
Antineoplastic Agents, Alkylating | 9 | 2020 | 614 | 1.690 |
Why?
|
Meningeal Neoplasms | 17 | 2024 | 1255 | 1.590 |
Why?
|
Glutarates | 13 | 2024 | 242 | 1.530 |
Why?
|
Meningioma | 15 | 2024 | 1221 | 1.420 |
Why?
|
Telomerase | 13 | 2024 | 750 | 1.390 |
Why?
|
Neurosurgical Procedures | 13 | 2024 | 2077 | 1.320 |
Why?
|
NAD | 6 | 2021 | 617 | 1.300 |
Why?
|
Dacarbazine | 7 | 2017 | 552 | 1.160 |
Why?
|
Central Nervous System Neoplasms | 7 | 2024 | 926 | 1.060 |
Why?
|
Magnetic Resonance Spectroscopy | 7 | 2024 | 3681 | 0.980 |
Why?
|
Craniopharyngioma | 7 | 2023 | 279 | 0.950 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 7 | 2024 | 904 | 0.930 |
Why?
|
Nicotinamide Phosphoribosyltransferase | 4 | 2020 | 85 | 0.840 |
Why?
|
Cyanides | 2 | 2020 | 82 | 0.770 |
Why?
|
Molecular Targeted Therapy | 14 | 2024 | 2823 | 0.770 |
Why?
|
Xenograft Model Antitumor Assays | 14 | 2024 | 3607 | 0.770 |
Why?
|
Guanidines | 2 | 2020 | 194 | 0.740 |
Why?
|
DNA Mismatch Repair | 3 | 2020 | 432 | 0.720 |
Why?
|
Echo-Planar Imaging | 1 | 2024 | 649 | 0.690 |
Why?
|
Glycoside Hydrolases | 1 | 2020 | 135 | 0.680 |
Why?
|
Pituitary Neoplasms | 8 | 2023 | 1324 | 0.670 |
Why?
|
Neoplasm Recurrence, Local | 20 | 2022 | 9404 | 0.660 |
Why?
|
Drug Resistance, Neoplasm | 10 | 2024 | 5329 | 0.620 |
Why?
|
Sirtuins | 1 | 2021 | 322 | 0.590 |
Why?
|
Spinal Cord Neoplasms | 2 | 2022 | 263 | 0.570 |
Why?
|
Melanoma | 10 | 2023 | 5700 | 0.570 |
Why?
|
Phthalazines | 1 | 2020 | 397 | 0.550 |
Why?
|
Promoter Regions, Genetic | 11 | 2024 | 5789 | 0.540 |
Why?
|
Piperazines | 5 | 2024 | 2547 | 0.540 |
Why?
|
Humans | 203 | 2024 | 766766 | 0.540 |
Why?
|
Meningeal Carcinomatosis | 3 | 2021 | 65 | 0.530 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 4 | 2024 | 705 | 0.530 |
Why?
|
TOR Serine-Threonine Kinases | 3 | 2019 | 2060 | 0.510 |
Why?
|
Mice, SCID | 8 | 2020 | 2628 | 0.510 |
Why?
|
Proto-Oncogene Proteins c-akt | 7 | 2024 | 2456 | 0.500 |
Why?
|
Neurosurgery | 2 | 2021 | 682 | 0.480 |
Why?
|
Hemangioblastoma | 1 | 2014 | 62 | 0.460 |
Why?
|
Radiographic Image Enhancement | 1 | 2018 | 873 | 0.450 |
Why?
|
Enzyme Inhibitors | 5 | 2024 | 3721 | 0.430 |
Why?
|
Phosphatidylinositol 3-Kinases | 3 | 2019 | 2881 | 0.420 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 304 | 0.420 |
Why?
|
DNA Modification Methylases | 4 | 2020 | 207 | 0.420 |
Why?
|
Neoplasm, Residual | 5 | 2021 | 1012 | 0.400 |
Why?
|
Cell Line, Tumor | 23 | 2024 | 17088 | 0.390 |
Why?
|
Magnetic Resonance Imaging | 29 | 2024 | 36567 | 0.390 |
Why?
|
DNA Repair Enzymes | 4 | 2020 | 342 | 0.390 |
Why?
|
Chromosome Deletion | 2 | 2015 | 1384 | 0.380 |
Why?
|
DNA-Binding Proteins | 11 | 2020 | 9611 | 0.370 |
Why?
|
Antineoplastic Agents | 13 | 2024 | 13643 | 0.360 |
Why?
|
Tumor Microenvironment | 11 | 2024 | 3944 | 0.360 |
Why?
|
DNA Repair | 1 | 2020 | 2050 | 0.350 |
Why?
|
Neoplasm Proteins | 3 | 2021 | 3601 | 0.350 |
Why?
|
Female | 94 | 2024 | 396520 | 0.340 |
Why?
|
Fusobacterium Infections | 1 | 2010 | 54 | 0.330 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 588 | 0.330 |
Why?
|
Pathology, Molecular | 1 | 2013 | 329 | 0.330 |
Why?
|
Stress, Physiological | 1 | 2017 | 1406 | 0.330 |
Why?
|
Cyclin-Dependent Kinase 6 | 2 | 2024 | 352 | 0.330 |
Why?
|
Lymphoma | 3 | 2024 | 1900 | 0.330 |
Why?
|
Brain Abscess | 1 | 2010 | 122 | 0.320 |
Why?
|
Adult | 67 | 2024 | 223307 | 0.310 |
Why?
|
Tumor Suppressor Proteins | 6 | 2020 | 2801 | 0.310 |
Why?
|
Brain | 18 | 2024 | 27159 | 0.310 |
Why?
|
Cytokines | 3 | 2021 | 7438 | 0.300 |
Why?
|
Middle Aged | 66 | 2024 | 223257 | 0.300 |
Why?
|
Prognosis | 22 | 2024 | 29948 | 0.300 |
Why?
|
Proto-Oncogene Proteins B-raf | 6 | 2023 | 2056 | 0.300 |
Why?
|
Tumor Cells, Cultured | 8 | 2020 | 6104 | 0.300 |
Why?
|
Telangiectasia, Hereditary Hemorrhagic | 1 | 2010 | 141 | 0.300 |
Why?
|
Craniotomy | 5 | 2021 | 736 | 0.290 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p15 | 2 | 2024 | 76 | 0.290 |
Why?
|
Gene Silencing | 3 | 2018 | 1504 | 0.290 |
Why?
|
Neurofibromin 2 | 3 | 2024 | 269 | 0.290 |
Why?
|
Male | 80 | 2024 | 364142 | 0.280 |
Why?
|
Neoplastic Stem Cells | 7 | 2017 | 1351 | 0.280 |
Why?
|
Clinical Trials as Topic | 4 | 2024 | 8045 | 0.280 |
Why?
|
Arteriovenous Malformations | 1 | 2010 | 396 | 0.280 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 2 | 2023 | 367 | 0.270 |
Why?
|
World Health Organization | 5 | 2024 | 1327 | 0.270 |
Why?
|
Aged | 54 | 2024 | 171343 | 0.270 |
Why?
|
Cell Proliferation | 13 | 2024 | 10445 | 0.270 |
Why?
|
Evoked Potentials, Somatosensory | 2 | 2021 | 240 | 0.260 |
Why?
|
Benzimidazoles | 2 | 2024 | 862 | 0.260 |
Why?
|
Young Adult | 29 | 2024 | 59939 | 0.260 |
Why?
|
Genotype | 4 | 2018 | 13036 | 0.260 |
Why?
|
Animals | 42 | 2024 | 168930 | 0.260 |
Why?
|
Protein Kinase Inhibitors | 11 | 2024 | 5690 | 0.250 |
Why?
|
Mice | 29 | 2024 | 81889 | 0.250 |
Why?
|
Streptococcal Infections | 1 | 2010 | 618 | 0.250 |
Why?
|
Aged, 80 and over | 25 | 2024 | 59550 | 0.240 |
Why?
|
Disease Management | 6 | 2019 | 2533 | 0.230 |
Why?
|
Genomics | 8 | 2023 | 5923 | 0.230 |
Why?
|
Single-Cell Analysis | 8 | 2024 | 2534 | 0.230 |
Why?
|
Disease Progression | 12 | 2023 | 13640 | 0.230 |
Why?
|
Foramen Magnum | 1 | 2024 | 41 | 0.220 |
Why?
|
Lung Neoplasms | 6 | 2024 | 13485 | 0.220 |
Why?
|
Imaging, Three-Dimensional | 4 | 2024 | 4047 | 0.220 |
Why?
|
Kaplan-Meier Estimate | 10 | 2020 | 6512 | 0.220 |
Why?
|
Gyrus Cinguli | 1 | 2010 | 1118 | 0.220 |
Why?
|
Microelectrodes | 2 | 2021 | 305 | 0.220 |
Why?
|
Cyclin-Dependent Kinase 4 | 2 | 2024 | 562 | 0.210 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 3 | 2023 | 635 | 0.210 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 7 | 2023 | 11872 | 0.210 |
Why?
|
Surgery, Computer-Assisted | 2 | 2020 | 996 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 10 | 2024 | 8621 | 0.210 |
Why?
|
Radiosurgery | 3 | 2019 | 1329 | 0.200 |
Why?
|
Treatment Outcome | 13 | 2024 | 65273 | 0.200 |
Why?
|
Survival Rate | 9 | 2024 | 12825 | 0.200 |
Why?
|
Neoplasm Metastasis | 4 | 2021 | 4891 | 0.190 |
Why?
|
Signal Transduction | 14 | 2023 | 23619 | 0.190 |
Why?
|
Proto-Oncogene Proteins c-myc | 2 | 2018 | 996 | 0.190 |
Why?
|
Retrospective Studies | 27 | 2024 | 81635 | 0.190 |
Why?
|
Chromosomes, Human, Pair 1 | 4 | 2018 | 640 | 0.190 |
Why?
|
Pyrimidines | 5 | 2022 | 3043 | 0.180 |
Why?
|
Oncolytic Virotherapy | 2 | 2017 | 520 | 0.180 |
Why?
|
NK Cell Lectin-Like Receptor Subfamily B | 1 | 2021 | 85 | 0.180 |
Why?
|
Immune Evasion | 1 | 2024 | 375 | 0.180 |
Why?
|
Methylation | 2 | 2020 | 1074 | 0.170 |
Why?
|
Aminopyridines | 1 | 2024 | 577 | 0.170 |
Why?
|
Chromosomes, Human, Pair 19 | 3 | 2018 | 350 | 0.170 |
Why?
|
Motor Cortex | 2 | 2021 | 1004 | 0.170 |
Why?
|
Hexokinase | 1 | 2020 | 125 | 0.170 |
Why?
|
Receptors, Nerve Growth Factor | 1 | 2021 | 199 | 0.170 |
Why?
|
Retinoblastoma Protein | 1 | 2023 | 670 | 0.170 |
Why?
|
Breast Neoplasms | 6 | 2020 | 21162 | 0.170 |
Why?
|
Neurotoxicity Syndromes | 1 | 2023 | 302 | 0.170 |
Why?
|
Skin Neoplasms | 2 | 2019 | 5861 | 0.160 |
Why?
|
Transcription Factor RelA | 1 | 2020 | 252 | 0.160 |
Why?
|
Sirtuin 1 | 1 | 2021 | 247 | 0.160 |
Why?
|
Medical Oncology | 2 | 2021 | 2340 | 0.160 |
Why?
|
Acrylamides | 2 | 2020 | 260 | 0.160 |
Why?
|
HSP90 Heat-Shock Proteins | 1 | 2022 | 422 | 0.160 |
Why?
|
DNA Mutational Analysis | 8 | 2024 | 4114 | 0.160 |
Why?
|
Immunohistochemistry | 8 | 2019 | 11061 | 0.160 |
Why?
|
Mitotic Index | 2 | 2015 | 160 | 0.160 |
Why?
|
Follow-Up Studies | 14 | 2024 | 39309 | 0.150 |
Why?
|
Introns | 2 | 2017 | 966 | 0.150 |
Why?
|
Neoplasms, Neuroepithelial | 1 | 2018 | 43 | 0.150 |
Why?
|
DNA Helicases | 2 | 2015 | 853 | 0.150 |
Why?
|
Kidney Neoplasms | 1 | 2015 | 4282 | 0.150 |
Why?
|
Myeloid Differentiation Factor 88 | 2 | 2020 | 582 | 0.150 |
Why?
|
Gene Deletion | 3 | 2024 | 2669 | 0.150 |
Why?
|
Transaminases | 1 | 2018 | 198 | 0.150 |
Why?
|
Ubiquitin Thiolesterase | 2 | 2020 | 456 | 0.150 |
Why?
|
Colorectal Neoplasms | 3 | 2015 | 6962 | 0.140 |
Why?
|
Neoplasms, Second Primary | 2 | 2022 | 1061 | 0.140 |
Why?
|
Adolescent | 20 | 2023 | 88904 | 0.140 |
Why?
|
Dystrophin | 1 | 2018 | 283 | 0.140 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2017 | 127 | 0.140 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 594 | 0.140 |
Why?
|
Oxazines | 1 | 2019 | 358 | 0.130 |
Why?
|
Antibodies, Bispecific | 1 | 2019 | 204 | 0.130 |
Why?
|
Brain Mapping | 3 | 2021 | 6596 | 0.130 |
Why?
|
Combined Modality Therapy | 5 | 2020 | 8540 | 0.130 |
Why?
|
Pentosyltransferases | 1 | 2015 | 62 | 0.130 |
Why?
|
Mitosis | 2 | 2018 | 1176 | 0.130 |
Why?
|
Gene Amplification | 2 | 2017 | 1088 | 0.130 |
Why?
|
Simplexvirus | 2 | 2017 | 805 | 0.130 |
Why?
|
T-Lymphocytes | 4 | 2023 | 10264 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 1 | 2021 | 789 | 0.120 |
Why?
|
Glutamic Acid | 2 | 2018 | 1181 | 0.120 |
Why?
|
Neoplasms | 6 | 2024 | 22350 | 0.120 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2024 | 4652 | 0.120 |
Why?
|
Critical Pathways | 1 | 2019 | 475 | 0.120 |
Why?
|
Pyridines | 2 | 2024 | 2888 | 0.120 |
Why?
|
Somatosensory Cortex | 2 | 2021 | 506 | 0.120 |
Why?
|
Rhabdoid Tumor | 1 | 2017 | 211 | 0.120 |
Why?
|
Intraoperative Care | 2 | 2019 | 768 | 0.120 |
Why?
|
Antigens, Neoplasm | 2 | 2021 | 1998 | 0.120 |
Why?
|
Sensitivity and Specificity | 5 | 2024 | 14652 | 0.120 |
Why?
|
Thalamus | 1 | 2021 | 1040 | 0.120 |
Why?
|
Drugs, Investigational | 1 | 2016 | 211 | 0.120 |
Why?
|
Cell Differentiation | 6 | 2024 | 11651 | 0.110 |
Why?
|
Tumor Burden | 3 | 2018 | 1900 | 0.110 |
Why?
|
Radiotherapy, Adjuvant | 4 | 2017 | 1787 | 0.110 |
Why?
|
Carcinoma, Papillary | 1 | 2019 | 791 | 0.110 |
Why?
|
Aneuploidy | 1 | 1998 | 573 | 0.110 |
Why?
|
Sequence Analysis, RNA | 3 | 2017 | 2039 | 0.110 |
Why?
|
Leukemia | 1 | 2022 | 1521 | 0.110 |
Why?
|
Chemotherapy, Adjuvant | 5 | 2019 | 3552 | 0.110 |
Why?
|
Spheroids, Cellular | 1 | 2015 | 328 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1374 | 0.110 |
Why?
|
Biopsy | 4 | 2019 | 6779 | 0.110 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 322 | 0.110 |
Why?
|
Terminology as Topic | 1 | 2021 | 1540 | 0.110 |
Why?
|
Evidence-Based Medicine | 4 | 2021 | 3692 | 0.110 |
Why?
|
Fatal Outcome | 1 | 2018 | 1838 | 0.110 |
Why?
|
Gene Targeting | 1 | 2016 | 840 | 0.110 |
Why?
|
Speech | 1 | 2018 | 555 | 0.110 |
Why?
|
Electric Stimulation | 4 | 2021 | 1736 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 3 | 2013 | 18075 | 0.110 |
Why?
|
NF-kappa B | 3 | 2020 | 2493 | 0.110 |
Why?
|
Aniline Compounds | 2 | 2018 | 1079 | 0.110 |
Why?
|
Watchful Waiting | 1 | 2017 | 492 | 0.110 |
Why?
|
Survival Analysis | 8 | 2021 | 10100 | 0.100 |
Why?
|
Histones | 3 | 2023 | 2593 | 0.100 |
Why?
|
Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 2 | 2024 | 43 | 0.100 |
Why?
|
Mice, Nude | 4 | 2020 | 3616 | 0.100 |
Why?
|
Random Allocation | 1 | 2017 | 2394 | 0.100 |
Why?
|
Repressor Proteins | 2 | 2015 | 2978 | 0.100 |
Why?
|
Immunotherapy | 5 | 2022 | 4747 | 0.100 |
Why?
|
Piperidines | 2 | 2020 | 1663 | 0.100 |
Why?
|
Prospective Studies | 7 | 2024 | 54871 | 0.100 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 2 | 2023 | 1667 | 0.100 |
Why?
|
Immunity | 1 | 2018 | 1002 | 0.100 |
Why?
|
Chromatin Assembly and Disassembly | 1 | 2016 | 630 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2015 | 594 | 0.100 |
Why?
|
Cell Cycle Proteins | 3 | 2023 | 3439 | 0.100 |
Why?
|
Point Mutation | 3 | 2016 | 1591 | 0.100 |
Why?
|
Nervous System Diseases | 2 | 2019 | 1659 | 0.100 |
Why?
|
Nerve Tissue Proteins | 3 | 2021 | 4400 | 0.100 |
Why?
|
Intraoperative Complications | 1 | 2019 | 1171 | 0.100 |
Why?
|
Immunity, Innate | 1 | 2024 | 3077 | 0.100 |
Why?
|
Autophagy | 2 | 2020 | 1346 | 0.100 |
Why?
|
src-Family Kinases | 1 | 2014 | 539 | 0.100 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2020 | 2948 | 0.100 |
Why?
|
Transfection | 2 | 2015 | 5754 | 0.090 |
Why?
|
Up-Regulation | 4 | 2024 | 4142 | 0.090 |
Why?
|
Cerebral Cortex | 2 | 2021 | 5753 | 0.090 |
Why?
|
Radiation Tolerance | 1 | 2013 | 476 | 0.090 |
Why?
|
Evoked Potentials, Motor | 1 | 2014 | 463 | 0.090 |
Why?
|
HEK293 Cells | 2 | 2020 | 4276 | 0.090 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2018 | 1762 | 0.090 |
Why?
|
Gene Expression Profiling | 5 | 2021 | 9525 | 0.090 |
Why?
|
Molecular Diagnostic Techniques | 1 | 2015 | 614 | 0.090 |
Why?
|
Temporal Lobe | 1 | 2018 | 1716 | 0.090 |
Why?
|
Streptococcus anginosus | 1 | 2010 | 25 | 0.090 |
Why?
|
Leukemia, Biphenotypic, Acute | 1 | 2010 | 32 | 0.090 |
Why?
|
Transcription Factors | 5 | 2023 | 12150 | 0.090 |
Why?
|
Frontal Lobe | 1 | 2016 | 1408 | 0.090 |
Why?
|
Blast Crisis | 1 | 2010 | 102 | 0.080 |
Why?
|
Enzyme Activation | 1 | 2015 | 3587 | 0.080 |
Why?
|
Cell Cycle | 4 | 2019 | 2926 | 0.080 |
Why?
|
Epigenomics | 1 | 2015 | 959 | 0.080 |
Why?
|
Tumor Escape | 2 | 2024 | 371 | 0.080 |
Why?
|
Brain Diseases | 1 | 2019 | 1552 | 0.080 |
Why?
|
RNA, Messenger | 4 | 2020 | 12791 | 0.080 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1996 | 0.080 |
Why?
|
Cell Lineage | 4 | 2024 | 2572 | 0.080 |
Why?
|
Nitriles | 1 | 2014 | 981 | 0.080 |
Why?
|
Polymerase Chain Reaction | 4 | 2020 | 6066 | 0.080 |
Why?
|
Epistaxis | 1 | 2010 | 117 | 0.080 |
Why?
|
Disease-Free Survival | 5 | 2020 | 6850 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2016 | 2839 | 0.080 |
Why?
|
Sindbis Virus | 1 | 1989 | 36 | 0.080 |
Why?
|
RNA-Binding Proteins | 2 | 2015 | 1884 | 0.080 |
Why?
|
Homozygote | 2 | 2024 | 1775 | 0.080 |
Why?
|
Quinolines | 1 | 2014 | 769 | 0.080 |
Why?
|
Epilepsy | 2 | 2021 | 3317 | 0.080 |
Why?
|
Chlorpromazine | 1 | 1989 | 111 | 0.080 |
Why?
|
Vesicular stomatitis Indiana virus | 1 | 1989 | 93 | 0.080 |
Why?
|
Electroencephalography | 2 | 2021 | 6282 | 0.080 |
Why?
|
Fusobacterium nucleatum | 1 | 2010 | 176 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2019 | 1434 | 0.080 |
Why?
|
Cancer Vaccines | 1 | 2016 | 1042 | 0.080 |
Why?
|
Receptors, Somatostatin | 1 | 2009 | 138 | 0.080 |
Why?
|
Language | 1 | 2018 | 1550 | 0.080 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2018 | 2885 | 0.080 |
Why?
|
Verapamil | 1 | 1989 | 242 | 0.080 |
Why?
|
Mosaicism | 1 | 2011 | 480 | 0.080 |
Why?
|
Immunologic Factors | 2 | 2015 | 1594 | 0.070 |
Why?
|
DNA Methylation | 5 | 2024 | 4427 | 0.070 |
Why?
|
Genetic Heterogeneity | 3 | 2019 | 735 | 0.070 |
Why?
|
Psychomotor Performance | 1 | 2016 | 1885 | 0.070 |
Why?
|
Fibroblasts | 2 | 2016 | 4166 | 0.070 |
Why?
|
Nausea | 2 | 2021 | 681 | 0.070 |
Why?
|
Apoptosis | 6 | 2019 | 9513 | 0.070 |
Why?
|
Executive Function | 1 | 2016 | 1396 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2011 | 562 | 0.070 |
Why?
|
Spinal Cord | 1 | 2016 | 1811 | 0.070 |
Why?
|
Monitoring, Intraoperative | 1 | 2014 | 947 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2018 | 2210 | 0.070 |
Why?
|
Muscle Weakness | 1 | 2010 | 412 | 0.070 |
Why?
|
Learning | 1 | 2016 | 1754 | 0.070 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 2024 | 1105 | 0.070 |
Why?
|
Memory | 1 | 2016 | 2192 | 0.070 |
Why?
|
Cytomegalovirus | 1 | 2011 | 754 | 0.070 |
Why?
|
Genetic Vectors | 1 | 2016 | 3401 | 0.070 |
Why?
|
Metabolomics | 1 | 2015 | 1675 | 0.070 |
Why?
|
Sequence Analysis, DNA | 2 | 2014 | 4780 | 0.070 |
Why?
|
Vertebral Artery Dissection | 1 | 2006 | 48 | 0.070 |
Why?
|
Thyroid Neoplasms | 1 | 2019 | 2355 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4522 | 0.060 |
Why?
|
Epigenesis, Genetic | 4 | 2024 | 3824 | 0.060 |
Why?
|
Seizures | 1 | 2019 | 2996 | 0.060 |
Why?
|
Diagnosis, Differential | 5 | 2016 | 12985 | 0.060 |
Why?
|
Histone Demethylases | 2 | 2020 | 328 | 0.060 |
Why?
|
Protein Kinases | 4 | 2016 | 1610 | 0.060 |
Why?
|
Attention | 1 | 2016 | 2413 | 0.060 |
Why?
|
Virus Replication | 2 | 2016 | 2457 | 0.060 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18330 | 0.060 |
Why?
|
Prostate | 2 | 2023 | 1757 | 0.060 |
Why?
|
Membrane Proteins | 2 | 2020 | 7868 | 0.060 |
Why?
|
Neovascularization, Pathologic | 2 | 2024 | 2631 | 0.060 |
Why?
|
Adenoma | 2 | 2020 | 2155 | 0.060 |
Why?
|
Genes, Neoplasm | 1 | 2007 | 369 | 0.060 |
Why?
|
Neoplasm Staging | 2 | 2019 | 11218 | 0.060 |
Why?
|
Child, Preschool | 7 | 2023 | 42577 | 0.060 |
Why?
|
Energy Metabolism | 1 | 2015 | 2903 | 0.060 |
Why?
|
Intracranial Hemorrhages | 1 | 2010 | 810 | 0.060 |
Why?
|
Glycolysis | 2 | 2020 | 838 | 0.060 |
Why?
|
Proteins | 1 | 1999 | 6002 | 0.060 |
Why?
|
Cognition Disorders | 1 | 2018 | 3967 | 0.060 |
Why?
|
Glucose | 1 | 2016 | 4340 | 0.060 |
Why?
|
Pulmonary Veins | 1 | 2010 | 758 | 0.060 |
Why?
|
Migraine with Aura | 1 | 2006 | 203 | 0.060 |
Why?
|
Cohort Studies | 4 | 2020 | 41710 | 0.060 |
Why?
|
RNA Polymerase III | 1 | 2024 | 59 | 0.050 |
Why?
|
DNA Copy Number Variations | 3 | 2020 | 2045 | 0.050 |
Why?
|
Neuropsychological Tests | 1 | 2016 | 7119 | 0.050 |
Why?
|
Chromosomal Instability | 1 | 2004 | 176 | 0.050 |
Why?
|
Ovarian Neoplasms | 1 | 2020 | 4904 | 0.050 |
Why?
|
Salicylanilides | 1 | 2022 | 15 | 0.050 |
Why?
|
Receptors, Notch | 2 | 2018 | 751 | 0.050 |
Why?
|
Algorithms | 2 | 2024 | 14072 | 0.050 |
Why?
|
Child | 9 | 2023 | 80668 | 0.050 |
Why?
|
Imidazoles | 2 | 2015 | 1168 | 0.050 |
Why?
|
Immunotherapy, Adoptive | 2 | 2023 | 1504 | 0.050 |
Why?
|
Genetic Variation | 2 | 2015 | 6612 | 0.050 |
Why?
|
Brain Edema | 1 | 2007 | 601 | 0.050 |
Why?
|
Consensus | 2 | 2023 | 3208 | 0.050 |
Why?
|
Time Factors | 5 | 2017 | 40149 | 0.050 |
Why?
|
Nucleotidyltransferases | 1 | 2024 | 242 | 0.050 |
Why?
|
Pediatrics | 1 | 2017 | 3614 | 0.050 |
Why?
|
Focal Adhesion Protein-Tyrosine Kinases | 1 | 2022 | 183 | 0.050 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 5387 | 0.050 |
Why?
|
Neurons | 1 | 2021 | 9515 | 0.050 |
Why?
|
Methylnitronitrosoguanidine | 1 | 2001 | 18 | 0.050 |
Why?
|
Wavelet Analysis | 1 | 2021 | 56 | 0.050 |
Why?
|
Monocytes | 1 | 2011 | 2600 | 0.050 |
Why?
|
Phylogeny | 2 | 2021 | 2840 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1938 | 0.050 |
Why?
|
Osteitis Deformans | 1 | 2001 | 54 | 0.050 |
Why?
|
Anorexia | 1 | 2021 | 153 | 0.050 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2024 | 505 | 0.050 |
Why?
|
Receptor, Notch1 | 1 | 2024 | 518 | 0.050 |
Why?
|
DNA | 3 | 2024 | 7208 | 0.050 |
Why?
|
Mice, Inbred ICR | 1 | 2021 | 361 | 0.040 |
Why?
|
Image Processing, Computer-Assisted | 2 | 2015 | 8926 | 0.040 |
Why?
|
Internship and Residency | 1 | 2021 | 5943 | 0.040 |
Why?
|
DNA Transposable Elements | 1 | 2024 | 764 | 0.040 |
Why?
|
Electronics | 1 | 2021 | 315 | 0.040 |
Why?
|
Quinazolines | 1 | 2007 | 1367 | 0.040 |
Why?
|
Matrix Metalloproteinase 13 | 1 | 2020 | 101 | 0.040 |
Why?
|
Exons | 2 | 2011 | 2392 | 0.040 |
Why?
|
Amino Acid Sequence | 3 | 2007 | 13411 | 0.040 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2021 | 361 | 0.040 |
Why?
|
Injections, Intralesional | 1 | 2020 | 280 | 0.040 |
Why?
|
Hepatitis | 1 | 2021 | 226 | 0.040 |
Why?
|
Feasibility Studies | 2 | 2021 | 5306 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2024 | 838 | 0.040 |
Why?
|
Extracellular Space | 1 | 2021 | 563 | 0.040 |
Why?
|
Viral Matrix Proteins | 1 | 2020 | 193 | 0.040 |
Why?
|
Electrophysiological Phenomena | 1 | 2021 | 309 | 0.040 |
Why?
|
Sequence Deletion | 1 | 2023 | 1494 | 0.040 |
Why?
|
Genome, Human | 2 | 2016 | 4443 | 0.040 |
Why?
|
Benzamides | 2 | 2018 | 1375 | 0.040 |
Why?
|
Tretinoin | 1 | 2022 | 524 | 0.040 |
Why?
|
Blotting, Western | 3 | 2017 | 5022 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1741 | 0.040 |
Why?
|
Physical Chromosome Mapping | 1 | 1999 | 183 | 0.040 |
Why?
|
Benzodiazepinones | 1 | 2018 | 50 | 0.040 |
Why?
|
Vision Disorders | 1 | 2006 | 1090 | 0.040 |
Why?
|
Sex Chromatin | 1 | 2018 | 19 | 0.040 |
Why?
|
Drug Administration Schedule | 2 | 2018 | 4853 | 0.040 |
Why?
|
Carcinogens | 1 | 2001 | 452 | 0.040 |
Why?
|
Diphenylamine | 1 | 2018 | 49 | 0.040 |
Why?
|
Genes, myc | 1 | 2020 | 391 | 0.040 |
Why?
|
Molecular Sequence Data | 3 | 2007 | 17608 | 0.040 |
Why?
|
Microsatellite Repeats | 1 | 2001 | 784 | 0.040 |
Why?
|
Infant | 4 | 2023 | 36461 | 0.040 |
Why?
|
Demecolcine | 1 | 1998 | 18 | 0.040 |
Why?
|
Pteridines | 1 | 2018 | 47 | 0.040 |
Why?
|
DNA Primers | 2 | 2001 | 2826 | 0.040 |
Why?
|
Nocodazole | 1 | 1998 | 95 | 0.040 |
Why?
|
Stereotaxic Techniques | 1 | 2020 | 551 | 0.040 |
Why?
|
Ecosystem | 1 | 2022 | 490 | 0.040 |
Why?
|
RNA, Small Interfering | 2 | 2018 | 3425 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2015 | 9244 | 0.040 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2024 | 3666 | 0.040 |
Why?
|
Polyamines | 1 | 2018 | 132 | 0.040 |
Why?
|
Base Sequence | 3 | 2016 | 12415 | 0.040 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 2 | 2014 | 1144 | 0.040 |
Why?
|
Neoadjuvant Therapy | 2 | 2019 | 2902 | 0.040 |
Why?
|
Lectins, C-Type | 1 | 2021 | 592 | 0.040 |
Why?
|
Cluster Analysis | 2 | 2015 | 2717 | 0.040 |
Why?
|
Pregnancy Proteins | 1 | 2018 | 222 | 0.040 |
Why?
|
Remission Induction | 1 | 2023 | 2413 | 0.040 |
Why?
|
Minor Histocompatibility Antigens | 1 | 2018 | 303 | 0.030 |
Why?
|
Observer Variation | 1 | 2023 | 2614 | 0.030 |
Why?
|
Quinazolinones | 1 | 2019 | 219 | 0.030 |
Why?
|
Quality of Life | 1 | 2019 | 13476 | 0.030 |
Why?
|
Thoracic Vertebrae | 1 | 2001 | 613 | 0.030 |
Why?
|
Mice, Inbred C57BL | 3 | 2021 | 22352 | 0.030 |
Why?
|
Triazoles | 1 | 2022 | 902 | 0.030 |
Why?
|
Phonetics | 1 | 2018 | 206 | 0.030 |
Why?
|
Vomiting | 1 | 2020 | 652 | 0.030 |
Why?
|
Exanthema | 1 | 2021 | 502 | 0.030 |
Why?
|
Patient Selection | 2 | 2019 | 4252 | 0.030 |
Why?
|
Delayed-Action Preparations | 1 | 2020 | 966 | 0.030 |
Why?
|
Paracrine Communication | 1 | 2018 | 277 | 0.030 |
Why?
|
Acoustic Stimulation | 1 | 2021 | 1253 | 0.030 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2018 | 684 | 0.030 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 857 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1345 | 0.030 |
Why?
|
NFATC Transcription Factors | 1 | 2018 | 392 | 0.030 |
Why?
|
Astrocytes | 1 | 2024 | 1351 | 0.030 |
Why?
|
Isoquinolines | 1 | 2017 | 350 | 0.030 |
Why?
|
Drug Carriers | 1 | 2020 | 702 | 0.030 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2016 | 169 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 16044 | 0.030 |
Why?
|
Cell Movement | 3 | 2020 | 5199 | 0.030 |
Why?
|
Nuclear Proteins | 2 | 2023 | 5795 | 0.030 |
Why?
|
Water | 1 | 2021 | 1417 | 0.030 |
Why?
|
Osteosarcoma | 1 | 2001 | 908 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 1999 | 2746 | 0.030 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1838 | 0.030 |
Why?
|
Spinal Fractures | 1 | 2001 | 702 | 0.030 |
Why?
|
Survival | 1 | 2015 | 160 | 0.030 |
Why?
|
Macrophages | 3 | 2020 | 5783 | 0.030 |
Why?
|
Fracture Fixation, Internal | 1 | 2001 | 982 | 0.030 |
Why?
|
Frozen Sections | 1 | 2015 | 153 | 0.030 |
Why?
|
Ki-67 Antigen | 1 | 2016 | 630 | 0.030 |
Why?
|
Macaca mulatta | 1 | 2021 | 2341 | 0.030 |
Why?
|
Case-Control Studies | 2 | 2024 | 22248 | 0.030 |
Why?
|
Gene Dosage | 1 | 2019 | 1211 | 0.030 |
Why?
|
RNA Interference | 2 | 2016 | 2827 | 0.030 |
Why?
|
Intraoperative Period | 1 | 2015 | 511 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2015 | 245 | 0.030 |
Why?
|
Fatigue | 1 | 2021 | 1555 | 0.030 |
Why?
|
Semantics | 1 | 2018 | 609 | 0.030 |
Why?
|
Reproducibility of Results | 2 | 2024 | 20144 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 2019 | 1227 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 305 | 0.030 |
Why?
|
Acetylation | 1 | 2016 | 1054 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2003 | 2463 | 0.030 |
Why?
|
Fever | 1 | 2021 | 1607 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Bullying | 1 | 2017 | 234 | 0.030 |
Why?
|
Gene Knockdown Techniques | 1 | 2018 | 1604 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2017 | 949 | 0.030 |
Why?
|
Skull Base | 1 | 2016 | 294 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2020 | 10745 | 0.030 |
Why?
|
Single-Blind Method | 1 | 2017 | 1587 | 0.030 |
Why?
|
Co-Repressor Proteins | 1 | 2014 | 190 | 0.030 |
Why?
|
Radiation Oncology | 1 | 2019 | 571 | 0.030 |
Why?
|
Gas Chromatography-Mass Spectrometry | 1 | 2014 | 355 | 0.030 |
Why?
|
Polymers | 1 | 2020 | 1624 | 0.030 |
Why?
|
Glycoproteins | 1 | 2001 | 2201 | 0.030 |
Why?
|
Interferon-gamma | 1 | 2021 | 3158 | 0.030 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2014 | 183 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 385 | 0.030 |
Why?
|
Colitis | 1 | 2021 | 1238 | 0.030 |
Why?
|
Phenotype | 3 | 2019 | 16724 | 0.030 |
Why?
|
RNA Splicing | 1 | 2017 | 903 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2024 | 3511 | 0.030 |
Why?
|
In Situ Hybridization, Fluorescence | 2 | 2014 | 2510 | 0.030 |
Why?
|
T-Lymphocyte Subsets | 1 | 2021 | 1814 | 0.030 |
Why?
|
Cloning, Molecular | 1 | 1998 | 4168 | 0.030 |
Why?
|
Comprehension | 1 | 2018 | 638 | 0.030 |
Why?
|
Empathy | 1 | 2017 | 474 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 2221 | 0.020 |
Why?
|
Surgical Wound Infection | 1 | 2001 | 1547 | 0.020 |
Why?
|
Baclofen | 1 | 1993 | 121 | 0.020 |
Why?
|
Predictive Value of Tests | 2 | 2021 | 15416 | 0.020 |
Why?
|
Lysine | 1 | 2016 | 997 | 0.020 |
Why?
|
Lumbar Vertebrae | 1 | 2001 | 1878 | 0.020 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 2001 | 0.020 |
Why?
|
Drug Monitoring | 1 | 2018 | 962 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2021 | 10384 | 0.020 |
Why?
|
Muscle Spasticity | 1 | 1993 | 159 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2023 | 3853 | 0.020 |
Why?
|
High-Throughput Screening Assays | 1 | 2017 | 938 | 0.020 |
Why?
|
Killer Cells, Natural | 1 | 2021 | 2210 | 0.020 |
Why?
|
Ligands | 1 | 2018 | 3275 | 0.020 |
Why?
|
beta Catenin | 1 | 2016 | 1048 | 0.020 |
Why?
|
Receptors, Cell Surface | 1 | 2021 | 2815 | 0.020 |
Why?
|
Hyperglycemia | 1 | 2020 | 1389 | 0.020 |
Why?
|
Magnetics | 1 | 2014 | 586 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2020 | 2474 | 0.020 |
Why?
|
Down-Regulation | 1 | 2018 | 2931 | 0.020 |
Why?
|
Receptor, Notch2 | 1 | 2011 | 90 | 0.020 |
Why?
|
Risk Factors | 5 | 2021 | 74881 | 0.020 |
Why?
|
Immunoconjugates | 1 | 2018 | 976 | 0.020 |
Why?
|
Neuroglia | 1 | 2016 | 960 | 0.020 |
Why?
|
Biopsy, Needle | 1 | 2015 | 1615 | 0.020 |
Why?
|
HL-60 Cells | 1 | 2011 | 365 | 0.020 |
Why?
|
Comparative Genomic Hybridization | 1 | 2011 | 474 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 818 | 0.020 |
Why?
|
Spinal Cord Diseases | 1 | 1993 | 291 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2016 | 1363 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2016 | 1028 | 0.020 |
Why?
|
Cranial Irradiation | 1 | 2012 | 392 | 0.020 |
Why?
|
Models, Genetic | 1 | 1999 | 3450 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 2 | 2020 | 4410 | 0.020 |
Why?
|
Cell Line | 2 | 2020 | 15563 | 0.020 |
Why?
|
Neural Stem Cells | 1 | 2016 | 895 | 0.020 |
Why?
|
Blood Cell Count | 1 | 2010 | 405 | 0.020 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2018 | 2571 | 0.020 |
Why?
|
Risk Assessment | 3 | 2021 | 24295 | 0.020 |
Why?
|
Loss of Heterozygosity | 1 | 2011 | 663 | 0.020 |
Why?
|
Proportional Hazards Models | 2 | 2014 | 12534 | 0.020 |
Why?
|
Ependymoma | 1 | 2012 | 326 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 2011 | 434 | 0.020 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 1998 | 1251 | 0.020 |
Why?
|
Polymorphism, Genetic | 1 | 1999 | 4249 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1982 | 0.020 |
Why?
|
RNA | 1 | 2018 | 2715 | 0.020 |
Why?
|
Research Design | 1 | 2024 | 6207 | 0.020 |
Why?
|
Viral Core Proteins | 1 | 1989 | 158 | 0.020 |
Why?
|
Bone Neoplasms | 1 | 2001 | 2561 | 0.020 |
Why?
|
DNA Damage | 1 | 2018 | 2467 | 0.020 |
Why?
|
Germ-Line Mutation | 1 | 2017 | 1885 | 0.020 |
Why?
|
Oncogenes | 1 | 2014 | 1231 | 0.020 |
Why?
|
Microglia | 1 | 2017 | 1370 | 0.020 |
Why?
|
Geriatric Assessment | 1 | 2015 | 1422 | 0.020 |
Why?
|
Flow Cytometry | 2 | 2010 | 5890 | 0.020 |
Why?
|
Adrenocorticotropic Hormone | 1 | 2009 | 618 | 0.020 |
Why?
|
Lymphocyte Activation | 1 | 2018 | 5503 | 0.020 |
Why?
|
Homeostasis | 1 | 2018 | 3342 | 0.020 |
Why?
|
Colonic Neoplasms | 1 | 1999 | 2534 | 0.020 |
Why?
|
Image Interpretation, Computer-Assisted | 1 | 2020 | 3359 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1057 | 0.020 |
Why?
|
Chick Embryo | 1 | 1989 | 972 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2020 | 3114 | 0.020 |
Why?
|
Sex Factors | 1 | 2020 | 10619 | 0.020 |
Why?
|
Odds Ratio | 1 | 2019 | 9661 | 0.020 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1989 | 1729 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2010 | 1892 | 0.020 |
Why?
|
Capsid | 1 | 1989 | 435 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2010 | 1606 | 0.020 |
Why?
|
Cells, Cultured | 2 | 2014 | 18984 | 0.020 |
Why?
|
Patient Care Team | 1 | 2017 | 2519 | 0.020 |
Why?
|
Salvage Therapy | 1 | 2012 | 1274 | 0.020 |
Why?
|
Genetic Markers | 1 | 2012 | 2603 | 0.020 |
Why?
|
Interleukin-10 | 1 | 2011 | 1182 | 0.020 |
Why?
|
Microsatellite Instability | 1 | 2009 | 726 | 0.020 |
Why?
|
Hospitals | 1 | 2019 | 3888 | 0.020 |
Why?
|
Gene Expression | 1 | 2018 | 7585 | 0.020 |
Why?
|
Scotoma | 1 | 2006 | 128 | 0.020 |
Why?
|
Age Factors | 2 | 2019 | 18397 | 0.020 |
Why?
|
Chemokines, CXC | 1 | 2007 | 420 | 0.020 |
Why?
|
Spinal Cord Injuries | 1 | 1993 | 927 | 0.020 |
Why?
|
Calcium | 1 | 2018 | 5783 | 0.020 |
Why?
|
Chemokine CXCL12 | 1 | 2007 | 457 | 0.010 |
Why?
|
Cytomegalovirus Infections | 1 | 2011 | 838 | 0.010 |
Why?
|
Protein Binding | 1 | 2016 | 9320 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3468 | 0.010 |
Why?
|
Pilot Projects | 1 | 2017 | 8728 | 0.010 |
Why?
|
Databases, Factual | 1 | 1999 | 8066 | 0.010 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 661 | 0.010 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1990 | 1362 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14471 | 0.010 |
Why?
|
Transcription, Genetic | 1 | 2016 | 7609 | 0.010 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1990 | 1802 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2013 | 4349 | 0.010 |
Why?
|
Mutation, Missense | 1 | 2011 | 2590 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 2 | 2019 | 20708 | 0.010 |
Why?
|
Viral Proteins | 1 | 1989 | 1801 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4880 | 0.010 |
Why?
|
Prostatic Neoplasms | 1 | 2003 | 11094 | 0.010 |
Why?
|
Fibroblast Growth Factors | 1 | 2007 | 871 | 0.010 |
Why?
|
Osteoprotegerin | 1 | 2001 | 179 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2020 | 26389 | 0.010 |
Why?
|
Neoplastic Cells, Circulating | 1 | 2007 | 949 | 0.010 |
Why?
|
Magnetic Resonance Angiography | 1 | 2006 | 1428 | 0.010 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2007 | 3804 | 0.010 |
Why?
|
Cell Survival | 1 | 2009 | 5748 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2019 | 7871 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12064 | 0.010 |
Why?
|
Receptors, Tumor Necrosis Factor | 1 | 2001 | 588 | 0.010 |
Why?
|
Membrane Glycoproteins | 1 | 1989 | 3702 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2001 | 1049 | 0.010 |
Why?
|
Clinical Protocols | 1 | 2003 | 1437 | 0.010 |
Why?
|
Sex Distribution | 1 | 2001 | 2274 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2015 | 12806 | 0.010 |
Why?
|
Age Distribution | 1 | 2001 | 2869 | 0.010 |
Why?
|
Drosophila melanogaster | 1 | 2004 | 1725 | 0.010 |
Why?
|
Liver | 1 | 1990 | 7571 | 0.010 |
Why?
|
Endothelial Cells | 1 | 2007 | 3581 | 0.010 |
Why?
|
Infusion Pumps, Implantable | 1 | 1993 | 158 | 0.010 |
Why?
|
Injections, Spinal | 1 | 1993 | 317 | 0.010 |
Why?
|
Drug Tolerance | 1 | 1993 | 365 | 0.010 |
Why?
|
Antigens, Ly | 1 | 1990 | 297 | 0.000 |
Why?
|
Genetic Testing | 1 | 2001 | 3591 | 0.000 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 1990 | 897 | 0.000 |
Why?
|
Mice, Inbred Strains | 1 | 1990 | 1767 | 0.000 |
Why?
|
Cytotoxicity, Immunologic | 1 | 1990 | 1352 | 0.000 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1990 | 1442 | 0.000 |
Why?
|
Decision Making | 1 | 1998 | 3951 | 0.000 |
Why?
|
Immunity, Cellular | 1 | 1990 | 1560 | 0.000 |
Why?
|
Incidence | 1 | 2001 | 21525 | 0.000 |
Why?
|
Anti-Bacterial Agents | 1 | 2001 | 7475 | 0.000 |
Why?
|
Double-Blind Method | 1 | 1993 | 12430 | 0.000 |
Why?
|
Multiple Sclerosis | 1 | 1993 | 3229 | 0.000 |
Why?
|
Liver Transplantation | 1 | 1990 | 2416 | 0.000 |
Why?
|